Sarah Bishop, APRN
Acute Care · Louisville, KYNPI 1861069908
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.4% of the total across 69 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations.
Across 69 payments — averaging $25.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$346
- Gilead$332
- Insmed, Inc.$297
- AbbVie$213
- Pfizer$142
- Shionogi Inc$138
- plus $293 from 6 others
What the payments were for
- Food & beverage$1,62892%
- Education$1348%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 14 | $346 |
| Gilead | 13 | $332 |
| Insmed, Inc. | 9 | $297 |
| AbbVie | 6 | $213 |
| Pfizer | 8 | $142 |
| Shionogi Inc | 2 | $138 |
| Melinta Therapeutics, LLC | 7 | $116 |
| Paratek Pharmaceuticals, Inc. | 5 | $69 |
| Ferring Pharmaceuticals Inc. | 2 | $39 |
| Medline Industries LP | 1 | $29 |
| Aimmune Therapeutics, Inc. | 1 | $23 |
| Oxford Immunotec USA Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,761 in reported general payments places this provider in the 80th percentile of 319 acute care providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Daptomycin | 14 | $25,609 |
| Vancomycin Hcl | 20 | $7,585 |
| Piperacillin-TazobactamPiperacillin Sodium/Tazobactam | 12 | $3,619 |
| CeftriaxoneCeftriaxone Sodium | 23 | $3,464 |
| Doxycycline Hyclate | 51 | $440 |
| Levofloxacin | 20 | $328 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $290 |
| Cephalexin | 16 | $183 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $167 |
Paid to pharmacies, not to this prescriber.
Other acute care in Louisville
- Jayla GreeneLouisville$5K
- Katherine WittmerLouisville$5K
- Sarah SmithLouisville$4K
- Charlene SandersLouisville$4K
- Adam CumminsLouisville$3K
- Kimberly MeyerLouisville$3K
- Nidhi MoreLouisville$3K
- Brian GackenbachLouisville$2K
- Jennifer AustinLouisville$2K
- Donnell ProctorLouisville$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.